Digital Health Startups

MindHelp A provides digital mental health screening and assessments for conditions including ADHD, anxiety, depression, and bipolar disorder, with consultations from GMC-licensed psychiatrists and medical doctors. The platform offers clinically-validated assessments and psychiatric coaching for individuals seeking mental health evaluation and support.

1 investor

MindBytes develops digital health tools and patient education solutions designed in collaboration with healthcare stakeholders and based on scientific evidence. The company serves healthcare organizations, pharmaceutical companies, and patients seeking evidence-based digital interventions to improve health outcomes.

1 investor

Mindly is an online platform that connects clients with psychologists for mental health therapy, offering client and specialist web dashboards. It also provides corporate therapy programs for companies' employees, therapy in five languages, online and offline webinars, and gift certificates.

1 investor

Mindoo builds AI agents that handle routine administrative and patient-facing tasks for healthcare teams, including patient intake, answering calls, scheduling, and post-visit follow-ups. It is designed for clinics and hospitals, with audit trails, consent handling, and region-specific data protections.

1 investor

Mindset Medical develops medical-grade software that uses remote photoplethysmography (rPPG) and deep learning to measure vital signs such as heart rate and respiratory rate through the camera on a patient's own smartphone, tablet, or computer. The contactless technology is aimed at healthcare platforms, health systems, health plans, and employers for telemedicine, remote patient monitoring, and population health use in the United States.

1 investor

Mindshare Medical (now RevealDx) builds clinical decision support software that uses image pattern recognition and deep learning to help radiologists and specialists detect and characterize diseases and guide follow-up procedures and treatments. It serves clinicians and healthcare organizations such as IDNs, ACOs, and risk-based clinics.

1 investor

Mindspan provides cognitive care through at-home screening and in-clinic evaluation by board-certified neurologists, reducing typical 18-month wait times to weeks for patients with memory changes, mild cognitive impairment, Alzheimer's disease, and other dementias. The platform combines diagnostic assessments with personalized treatment plans and ongoing family-centered support to address cognitive health conditions.

1 investor

SONA is a wearable, AI-powered vagus nerve stimulator that reads users' biometric signals (such as HRV) to deliver personalised stimulation protocols aimed at reducing stress and regulating the nervous system. Sold with a companion app and onboarding support, it is a consumer wellness device positioned for individuals managing chronic stress.

1 investor

Minset builds an AI-driven revenue cycle management platform for healthcare providers, aimed at reducing claim denials and getting practices paid faster. It positions itself as an autonomous alternative to manual, staff-heavy billing processes.

1 investor

Miphic provides imaging-based diagnostic screening of mitochondrial function to identify drug efficacy and personalized treatment options for cancer, neurodegenerative disease, diabetes, and aging-related conditions. The platform screens up to 96 conditions simultaneously to support drug discovery, personalized medicine selection, and metabolic research.

1 investor

MiraDx develops genetic biomarker tests, such as PREVIOTOX and PROSTOX Ultra, that help physicians assess cancer patients' risk of treatment-related toxicity and response to therapies like immunotherapy and radiation. The company applies novel biomarkers, including the inherited KRAS-variant, to support more personalized cancer care decisions.

1 investor

Mira Health offers an AI phone concierge that answers patient calls around the clock, identifies the reason for each call, and routes patients to the right provider within a medical practice. It also handles eligibility and cost-of-care checks, refills, messaging, and scheduling for multi-provider clinics.

1 investor

Miramace offers a personal health advocate service, covered by Medicare, that helps individuals set healthcare goals and provides ongoing support via message or call. It serves Medicare-eligible patients seeking guidance in navigating their care.

1 investor

Mirada develops medical imaging software solutions that personalize image-guided cancer treatment to improve patient outcomes. The company combines scientific advancement, technical innovation, and clinical expertise to accelerate cancer care delivery.

1 investor

Mirae is a mobile application that helps people with inflammatory bowel disease understand their condition, track clinical and daily experience data, and prepare for conversations with healthcare providers. The app combines patient-reported symptoms and clinical information to give people with IBD a clearer picture of their disease without replacing clinical judgment.

1 investor

Miraka provides clinician-led cardiac care delivered at home, using continuous real-time monitoring of biometrics such as heart rhythm, blood oxygen, and blood pressure to detect emerging risks and escalate treatment early. It serves cardiac patients between hospital visits, aiming to reduce hospital readmissions, and works via physician referrals at health systems.

1 investor

Miranza operates a network of ophthalmology clinics in Spain specializing in eye care and vision health, offering treatments such as cataract surgery and intraocular lens implants. It serves patients across more than 30 clinics in cities including Barcelona, Madrid, Alicante, Tenerife, and Seville.

1 investor

Mireca develops treatments for rare, inherited retinal degenerations based on scientific research originating from the EU-funded DRUGSFORD project. The company translates basic research into therapeutic candidates targeting photoreceptor degeneration diseases such as retinitis pigmentosa and achromatopsia.

1 investor

Miri offers a subscription-based health program aimed at GLP-1 medication users, helping providers retain customers through ongoing monthly engagement. The product is positioned to improve program retention and generate recurring revenue for the businesses that deploy it.

1 investor

Misala adapts, validates, manufactures, and distributes on-patent diagnostics, devices, and therapeutics from universities and research labs for African women's health contexts, using a staged "Reset, Detect, Treat" framework. It serves women and clinicians, starting with a consumer wellness and education arm before expanding into diagnostics and therapeutics adapted for African populations and healthcare systems.

1 investor

Mishe operates a direct payor platform that connects employers and members directly with health systems and providers, enabling same-day payments to providers and zero-cost network benefits for members. The platform handles direct contracting, care coordination, and claims processing, including pre-funded treatments with same-day EFT remittance.

1 investor

Mission Accomplished is an AI-powered app that helps parents and caregivers break down everyday challenges with their children into small, manageable steps and understand what may be behind a child's behavior. It also connects teachers and clinicians such as SLPs, OTs, and behavioral specialists so everyone supporting a child works from the same information.

1 investor

Mission Driven Tech develops medical devices and educational content focused on cervical and uterine cancer treatment. The company offers brachytherapy devices for gynecological cancers and outcome research resources for healthcare professionals.

1 investor

MKCL offers educational products and services focused on bridging the digital divide, including IT certification courses, test preparation platforms, and a secure assessment and certification framework used by universities and government institutions.

1 investor